CLINICAL_TRIALS
trial_result
· 2020-05-20
Clinical Trial Update: A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa [Phase 2]
Summary
Phase 2 trial summary of INCB054707 in hidradenitis suppurativa completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2020-05-20